Patent details
90312 Product Name: S-N-éthyl-3-[(1-diméthyl-amino)éthyl]-N-méthyl- phénylcarbamate ou un sel pharmaceutiquement acceptable de celui-ci en particulier le tartrate hydrogène. (EXELON® - RIVASTIGMINE)
Basic Information
- Publication number:
- 90312
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP861028124
- Legal Status:
- Expired
- Application number:
- 90312
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- EU/1/98/066/001 à EU/1/98/066/012
- Marketing Authorization Type:
- Marketing Authorization Date:
- 12/05/1998
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
2
- Marketing Authorization Number:
- IKS Nr., 54275
- Marketing Authorization Type:
- Marketing Authorization Date:
- 31/07/1997
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 04/11/1998
- First Marketing Authorization date:
- 31/07/1997
- Grant date:
- 06/01/1999
- Activation date:
- 04/03/2006
- Publication date:
- 06/01/1999
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 04/03/2011
- SPC Extension Expiration:
- 04/03/2011
- Rejection date:
- Withdrawal date:
Owner
- From:
- 04/11/1998
- Name:
- PROTERRA AG
- Address:
- Poststrasse 9, CH-6300 Zug, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 04/11/1998
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
| Filing date | Document type | Number of pages |
|---|